Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06315257 · ClinicalTrials.gov registry record · Phase 1

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

A Phase 1 study of Cervical Cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Recruiting
Registry status
Phase 1
Development phase
32
Enrollment target
2
Study locations

NCT06315257 is a Phase 1 study of Cervical Cancer that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 32 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06315257, a Phase 1 study of Cervical Cancer, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

RECRUITING
Registry status
Phase 1
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients who have completed primary definitive therapy.

Conditions Studied

Cervical Cancer

Interventions

  • DRUG PVX7

Study Locations (2)

Alabama

  • The University of Alabama at Birmingham - Birmingham

Maryland

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-09-22
Est. Completion 2029-10
Phase Phase 1

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

523 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06315257

The ClinicalTrials.gov registry entry for NCT06315257 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which PVX7 is the first listed.

NCT06315257 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Maryland.

Frequently Asked Questions

What is clinical trial NCT06315257 about?

NCT06315257 is a clinical study titled "A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients". A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients who have completed primary definitive therapy.

What is the current status of trial NCT06315257?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2025-09-22. Estimated completion is 2029-10.

What conditions does trial NCT06315257 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT06315257?

The interventions under investigation include: PVX7 (DRUG).

Who is sponsoring clinical trial NCT06315257?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06315257 being conducted?

This trial has 2 study locations across Alabama, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cervical Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.